Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences
Pasireotide-LAR is recommended as a second-line treatment for patients with acromegaly. Although the effects of pasireotide-LAR have been well characterized in clinical studies, real-practice evidence is scant, especially in the long term and within the individualization of therapy in patients with...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BioExcel Publishing Ltd
2024-05-01
|
| Rangatū: | Drugs in Context |
| Ngā marau: | |
| Urunga tuihono: | https://www.drugsincontext.com/long-term-pasireotide-lar-treatment-in-the-personalized-therapy-of-patients-with-complex-acromegaly-a-collection-of-clinical-experiences/ |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|